NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 197 filers reported holding NEVRO CORP in Q3 2021. The put-call ratio across all filers is 2.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $767 | -68.3% | 30,177 | -54.9% | 0.01% | -76.7% |
Q1 2023 | $2,419 | -12.2% | 66,933 | -3.8% | 0.03% | -23.1% |
Q4 2022 | $2,755 | -99.8% | 69,582 | +378.3% | 0.04% | +457.1% |
Q4 2021 | $1,179,000 | +298.3% | 14,549 | +471.2% | 0.01% | +250.0% |
Q3 2021 | $296,000 | -45.3% | 2,547 | -22.0% | 0.00% | -60.0% |
Q2 2021 | $541,000 | -53.6% | 3,265 | -61.0% | 0.01% | -58.3% |
Q1 2021 | $1,166,000 | +104.6% | 8,363 | +104.2% | 0.01% | -29.4% |
Q3 2020 | $570,000 | +97.9% | 4,095 | -44.8% | 0.02% | -58.5% |
Q4 2018 | $288,000 | +38.5% | 7,416 | +103.0% | 0.04% | +28.1% |
Q3 2018 | $208,000 | – | 3,654 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |